Additionally, the downregulation of CREBZF restored the expression of cyclin D1, cyclin E1, and BCL-2 and decreased BAX expression in circPAPD4-overexpressing BC cells (Fig. 5I). The gene discussed is BCL2; the disease is breast cancer.